‘risk-benefit-
WHO seeks ‘additional clarifications’ from Bharat Biotech for Covaxin to conduct final ‘risk-benefit-
admin
By PTI UNITED NATIONS: The World Health Organisation’s technical advisory group on Tuesday sought “additional clarifications” from Bharat Biotech for ...
